Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Goodrich Katherine
Over the trailing 90 days, Goodrich Katherine (Director at Tarsus Pharmaceuticals, Inc.) sold $183K of stock in TARS, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- TARS
- Window
- Trailing 90 days · 5 transactions · CIK 2044770
- Net activity
- −$183K ($0 bought · $183K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | 5 | — | $183K | −$183K |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-25 | TARS | Buy | 3.8K | $0 | Grant, award or other acquisition |
| 2026-06-25 | TARS | Buy | 2.4K | $0 | Grant, award or other acquisition |
| 2026-06-15 | TARS | Sell | 3.0K | $183K | Open market or private sale |
| 2026-06-12 | TARS | Sell | 3.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-12 | TARS | Buy | 3.0K | $0 | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Goodrich's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.